英国国家转诊中心单年度系统性自身炎症性疾病诊断情况
该研究回顾性分析了2022年英国一家以成人为主的国家级转诊中心所有新诊患者的病历,旨在了解系统性自身炎症性疾病(SAID)的病例构成与人口学特征。306例患者中121例(39.5%)诊断为SAID,最常见为家族性地中海热(31%)、特发性复发性心包炎(14%)和未分化SAID(11%),且存在显著诊断延迟。
要点
- 306例新诊患者中121例(39.5%)诊断为SAID,其中79%为新诊断、21%由儿科转介。
- SAID患者中59%为男性,49%的基因结果支持单基因病。
- 新诊断SAID患者中位诊断延迟4.5年(IQR 1-12.75),晚发成人型延迟6年(IQR 2-8.5)。
核心结论
- 该以成人为主的转诊中心单年度内诊断了数量与种类均具临床重要性的SAID病例。
- SAID诊断仍具挑战性,研究发现存在显著的诊断延迟。
研究设计与样本
- 回顾性审查2022年英国一家以成人SAID为主的国家级转诊中心所有新诊患者的病历。
- 基因检测采用24个SAID相关基因的新一代测序(NGS) panel或单基因Sanger测序。
主要发现
- 306例患者中121例(39.5%)诊断为SAID;SAID患者中59%为男性,79%为新诊断,21%由儿科转介。
- 121例SAID患者中59例(49%)的基因结果支持单基因病。
- 最常见诊断为家族性地中海热(FMF,31%)、特发性复发性心包炎(14%)和未分化SAID(11%)。
- 诊断时中位年龄:转介患者7岁(IQR 3.75-12.5),新诊断患者35岁(IQR 22-45.75),新诊断晚发成人型SAID患者65岁(IQR 57.75-74.25)。
- 中位诊断延迟:转介SAID 2年(IQR 0-5.5),新诊断4.5年(IQR 1-12.75),晚发SAID 6年(IQR 2-8.5)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The diagnosis of systemic autoinflammatory diseases (SAIDs) is frequently missed or delayed. The establishment of specialist clinics and the availability of genetic testing enables increased diagnosis of these disorders. We aimed to study the case mix and demographics of patients referred to a UK national centre for primarily adult SAID. METHODS: The medical records of all new patients seen in 2022 were reviewed. Genetic testing either involved a next-generation sequencing (NGS) panel of 24 SAID-related genes, or Sanger sequencing of individual genes. RESULTS: Of 306 patients, 121 (39.5%) were diagnosed with SAID. Of the patients with SAID, 59% were male, 79% were new diagnoses, and 21% had transitioned from paediatric care. The new-diagnosis group were primarily adults and included patients with SAIDs with known late-adult onset. Fifty-nine of the patients with SAID (49%) had genetic results supportive of monogenic disease. The most frequent diagnoses were FMF (31%), idiopathic recurrent pericarditis (14%), and undifferentiated SAID (11%). The median age at diagnosis was 7 years [interquartile range (IQR) 3.75-12.5] for transition patients, 35 years (IQR 22-45.75) for newly diagnosed patients, and 65 years (IQR 57.75-74.25) for newly diagnosed late-adult-onset SAIDs. The median diagnostic delay was 2 years (IQR 0-5.5) in transition SAID, 4.5 years (IQR 1-12.75) in new diagnoses, and 6 years (IQR 2-8.5) in late-onset SAID. CONCLUSION: The clinic sees a clinically important number and range of SAID diagnoses in a primarily adult population. SAID diagnosis remains challenging, and it was found that there were significant diagnostic delays.
引用
- Caterson HC, Papadopoulou C, Peet C, et al. Systemic autoinflammatory disease diagnoses in a single year from a UK national referral centre. Rheumatology (Oxford). 2025. PMID: 40128169. doi:10.1093/rheumatology/keaf165
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。